Clarissa Elysia Fu

1.7k total citations · 1 hit paper
20 papers, 415 citations indexed

About

Clarissa Elysia Fu is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Clarissa Elysia Fu has authored 20 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 9 papers in Hepatology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Clarissa Elysia Fu's work include Liver Disease Diagnosis and Treatment (16 papers), Liver Disease and Transplantation (7 papers) and Diet, Metabolism, and Disease (6 papers). Clarissa Elysia Fu is often cited by papers focused on Liver Disease Diagnosis and Treatment (16 papers), Liver Disease and Transplantation (7 papers) and Diet, Metabolism, and Disease (6 papers). Clarissa Elysia Fu collaborates with scholars based in Singapore, United States and Hong Kong. Clarissa Elysia Fu's co-authors include Mark Muthiah, Cheng Han Ng, Darren Jun Hao Tan, Wen Hui Lim, Kai En Chan, Daniel Q. Huang, Nicholas Syn, Rebecca Wenling Zeng, Jie Ning Yong and Jieling Xiao and has published in prestigious journals such as PLoS ONE, Hepatology and The American Journal of Cardiology.

In The Last Decade

Clarissa Elysia Fu

19 papers receiving 408 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Patterns in Cancer Incidence Among People Younger Than 50 Years in the US, 2010 to 2019

2023 93 citations Benjamin Koh, Darren Jun Hao Tan et al. JAMA Network Open profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Clarissa Elysia Fu Singapore	12	266	122	107	69	56	20	415
Rebecca Wenling Zeng Singapore	11	269 1.0×	122 1.0×	112 1.0×	68 1.0×	56 1.0×	18	412
Cameron T. Locklear United States	6	354 1.3×	221 1.8×	135 1.3×	51 0.7×	86 1.5×	7	503
Jie‐Jun Hu China	11	159 0.6×	58 0.5×	128 1.2×	68 1.0×	57 1.0×	23	466
Xian Yu United States	11	481 1.8×	269 2.2×	179 1.7×	46 0.7×	69 1.2×	27	647
Mona Lalehzari United States	3	388 1.5×	303 2.5×	79 0.7×	37 0.5×	72 1.3×	5	475
Kuan‐Chieh Fang Taiwan	7	233 0.9×	190 1.6×	77 0.7×	33 0.5×	53 0.9×	10	296
Claudia Sanna Italy	8	161 0.6×	100 0.8×	69 0.6×	27 0.4×	41 0.7×	15	306
Benjamin Nah Singapore	11	187 0.7×	113 0.9×	67 0.6×	20 0.3×	30 0.5×	25	271
Rebecca Harris United Kingdom	9	342 1.3×	290 2.4×	67 0.6×	22 0.3×	90 1.6×	15	439
Jen Jung Pan United States	6	214 0.8×	107 0.9×	105 1.0×	16 0.2×	40 0.7×	6	343

Countries citing papers authored by Clarissa Elysia Fu

Since Specialization

Citations

This map shows the geographic impact of Clarissa Elysia Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clarissa Elysia Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clarissa Elysia Fu more than expected).

Fields of papers citing papers by Clarissa Elysia Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clarissa Elysia Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clarissa Elysia Fu. The network helps show where Clarissa Elysia Fu may publish in the future.

Co-authorship network of co-authors of Clarissa Elysia Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Clarissa Elysia Fu. A scholar is included among the top collaborators of Clarissa Elysia Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clarissa Elysia Fu. Clarissa Elysia Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Wei, et al.. (2025). Artificial intelligence in the prediction of glaucoma development and progression: A systematic review. Survey of Ophthalmology. 71(1). 235–247.

Zeng, Rebecca Wenling, Jie Ning Yong, Darren Jun Hao Tan, et al.. (2023). Meta‐analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin. Alimentary Pharmacology & Therapeutics. 57(6). 600–609. 52 indexed citations

Lim, Wen Hui, Caitlyn Tan, Jieling Xiao, et al.. (2023). De novo metabolic syndrome after liver transplantation: a meta-analysis on cumulative incidence, risk factors, and outcomes. Liver Transplantation. 29(4). 413–421. 7 indexed citations

Quek, Jingxuan, Darren Jun Hao Tan, Kai En Chan, et al.. (2023). Quality Assessment of Ultrasound and Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance: A Systematic Review and Meta-Analysis. Digestive Diseases. 41(5). 757–766. 6 indexed citations

Fu, Clarissa Elysia, Jie Ning Yong, Cheng Han Ng, et al.. (2023). The prognostic value of including non‐alcoholic fatty liver disease in the definition of metabolic syndrome. Alimentary Pharmacology & Therapeutics. 57(9). 979–987. 12 indexed citations

Lin, Chaoxing, Yip Han Chin, Bryan Chong, et al.. (2023). Mortality, Cardiovascular, and Medication Outcomes in Patients With Myocardial Infarction and Underweight in a Meta-Analysis of 6.3 Million Patients. The American Journal of Cardiology. 196. 1–10. 11 indexed citations

Tan, Darren Jun Hao, Kai En Chan, Zhen Yu Wong, et al.. (2023). Global Epidemiology of Cirrhosis: Changing Etiological Basis and Comparable Burden of Nonalcoholic Steatohepatitis between Males and Females. Digestive Diseases. 41(6). 900–912. 15 indexed citations

Koh, Benjamin, Darren Jun Hao Tan, Cheng Han Ng, et al.. (2023). Patterns in Cancer Incidence Among People Younger Than 50 Years in the US, 2010 to 2019. JAMA Network Open. 6(8). e2328171–e2328171. 93 indexed citations breakdown →

Ng, Cheng Han, Ansel Shao Pin Tang, Jieling Xiao, et al.. (2023). Safety and tolerability of obeticholic acid in chronic liver disease: a pooled analysis of 1878 individuals. Hepatology Communications. 7(3). e0005–e0005. 23 indexed citations

10.

Lim, Wen Hui, Cheng Han Ng, Darren Jun Hao Tan, et al.. (2023). Donor Diabetes and Steatosis Affects Recipient Survival Following Liver Transplantation Based on Etiology of Liver Cirrhosis. Transplantation. 108(2). 473–482. 3 indexed citations

11.

Ng, Cheng Han, Kai En Chan, Mark Muthiah, et al.. (2023). Examining the interim proposal for name change to steatotic liver disease in the US population. Hepatology. 77(5). 1712–1721. 8 indexed citations

12.

Tay, Phoebe Wen Lin, Cheng Han Ng, Snow Yunni Lin, et al.. (2022). Placebo Adverse Events in Non-alcoholic Steatohepatitis Clinical Trials: A Pooled Analysis of 2,944 Participants. The American Journal of Gastroenterology. 118(4). 645–653. 6 indexed citations

13.

Fu, Clarissa Elysia, Cheng Han Ng, Nicholas Chew, et al.. (2022). A poor perspective of self weight significantly increases adverse outcomes in non-alcoholic fatty liver disease (NAFLD). Frontiers in Medicine. 9. 977552–977552. 3 indexed citations

14.

Muthiah, Mark, Cheng Han Ng, Kai En Chan, et al.. (2022). Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis. Annals of Hepatology. 28(1). 100762–100762. 26 indexed citations

15.

Lim, Wen Hui, Kai En Chan, Cheng Han Ng, et al.. (2022). A qualitative systematic review of anonymous/unspecified living kidney and liver donors’ perspectives. PLoS ONE. 17(12). e0277792–e0277792. 5 indexed citations

16.

Tang, Ansel Shao Pin, Cheng Han Ng, Kai En Chan, et al.. (2022). Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 21(7). 1750–1760.e12. 60 indexed citations

17.

Chan, Kai En, Cheng Han Ng, Clarissa Elysia Fu, et al.. (2022). The Spectrum and Impact of Metabolic Dysfunction in MAFLD: A Longitudinal Cohort Analysis of 32,683 Overweight and Obese Individuals. Clinical Gastroenterology and Hepatology. 21(10). 2560–2569.e15. 19 indexed citations

18.

Xiao, Jieling, Cheng Han Ng, Kai En Chan, et al.. (2022). Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD – An Umbrella Overview of Systematic Review of Meta-Analysis. Journal of Clinical and Experimental Hepatology. 13(4). 656–665. 28 indexed citations

19.

Fu, Clarissa Elysia, Cheng Han Ng, Jie Ning Yong, et al.. (2022). A Meta-analysis on Associated Risk of Mortality in Nonalcoholic Fatty Liver Disease. Endocrine Practice. 29(1). 33–39. 23 indexed citations

20.

Ng, Cheng Han, Wen Hui Lim, Yip Han Chin, et al.. (2022). Living in the non‐alcoholic fatty liver disease silent epidemic: a qualitative systematic review of patients' perspectives. Alimentary Pharmacology & Therapeutics. 56(4). 570–579. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact